vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Turning Point Brands, Inc. (TPB). Click either name above to swap in a different company.

Turning Point Brands, Inc. is the larger business by last-quarter revenue ($121.0M vs $83.1M, roughly 1.5× PROCEPT BioRobotics Corp). Turning Point Brands, Inc. runs the higher net margin — 6.8% vs -38.1%, a 44.8% gap on every dollar of revenue. On growth, Turning Point Brands, Inc. posted the faster year-over-year revenue change (29.2% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 20.7%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Turning Point Australia (TPAUS) is a conservative lobby group based in Australia, affiliated with Turning Point USA but independent of it. Founded by Joel Jammal and first registered in 2023, the group has become active in trying to influence the outcome of the 2026 South Australian state election in March 2026.

PRCT vs TPB — Head-to-Head

Bigger by revenue
TPB
TPB
1.5× larger
TPB
$121.0M
$83.1M
PRCT
Growing faster (revenue YoY)
TPB
TPB
+9.0% gap
TPB
29.2%
20.2%
PRCT
Higher net margin
TPB
TPB
44.8% more per $
TPB
6.8%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
20.7%
TPB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
TPB
TPB
Revenue
$83.1M
$121.0M
Net Profit
$-31.6M
$8.2M
Gross Margin
64.9%
55.9%
Operating Margin
-4.1%
16.5%
Net Margin
-38.1%
6.8%
Revenue YoY
20.2%
29.2%
Net Profit YoY
-27.9%
239.8%
EPS (diluted)
$-0.56
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
TPB
TPB
Q1 26
$83.1M
Q4 25
$76.4M
$121.0M
Q3 25
$83.3M
$119.0M
Q2 25
$79.2M
$116.6M
Q1 25
$69.2M
$106.4M
Q4 24
$68.2M
$93.7M
Q3 24
$58.4M
$90.7M
Q2 24
$53.4M
$93.2M
Net Profit
PRCT
PRCT
TPB
TPB
Q1 26
$-31.6M
Q4 25
$-29.8M
$8.2M
Q3 25
$-21.4M
$21.1M
Q2 25
$-19.6M
$14.5M
Q1 25
$-24.7M
$14.4M
Q4 24
$-18.9M
$2.4M
Q3 24
$-21.0M
$12.4M
Q2 24
$-25.6M
$13.0M
Gross Margin
PRCT
PRCT
TPB
TPB
Q1 26
64.9%
Q4 25
60.6%
55.9%
Q3 25
64.8%
59.2%
Q2 25
65.4%
57.1%
Q1 25
63.9%
56.0%
Q4 24
64.0%
56.0%
Q3 24
63.2%
55.6%
Q2 24
59.0%
54.1%
Operating Margin
PRCT
PRCT
TPB
TPB
Q1 26
-4.1%
Q4 25
-40.6%
16.5%
Q3 25
-27.8%
21.8%
Q2 25
-28.0%
22.6%
Q1 25
-39.7%
21.8%
Q4 24
-28.9%
19.1%
Q3 24
-38.4%
22.9%
Q2 24
-50.3%
24.5%
Net Margin
PRCT
PRCT
TPB
TPB
Q1 26
-38.1%
Q4 25
-39.1%
6.8%
Q3 25
-25.7%
17.7%
Q2 25
-24.7%
12.4%
Q1 25
-35.8%
13.5%
Q4 24
-27.6%
2.6%
Q3 24
-35.9%
13.6%
Q2 24
-48.0%
14.0%
EPS (diluted)
PRCT
PRCT
TPB
TPB
Q1 26
$-0.56
Q4 25
$-0.54
$0.40
Q3 25
$-0.38
$1.13
Q2 25
$-0.35
$0.79
Q1 25
$-0.45
$0.79
Q4 24
$-0.34
$0.15
Q3 24
$-0.40
$0.68
Q2 24
$-0.50
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
TPB
TPB
Cash + ST InvestmentsLiquidity on hand
$245.6M
$222.8M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$372.0M
Total Assets
$487.1M
$763.8M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
TPB
TPB
Q1 26
$245.6M
Q4 25
$286.5M
$222.8M
Q3 25
$294.3M
$201.2M
Q2 25
$302.7M
$109.9M
Q1 25
$316.2M
$99.6M
Q4 24
$333.7M
$48.9M
Q3 24
$196.8M
$33.6M
Q2 24
$214.1M
$142.2M
Total Debt
PRCT
PRCT
TPB
TPB
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
TPB
TPB
Q1 26
$347.7M
Q4 25
$365.9M
$372.0M
Q3 25
$380.3M
$358.2M
Q2 25
$385.8M
$224.8M
Q1 25
$389.2M
$203.4M
Q4 24
$402.2M
$190.4M
Q3 24
$241.2M
$185.7M
Q2 24
$251.8M
$172.8M
Total Assets
PRCT
PRCT
TPB
TPB
Q1 26
$487.1M
Q4 25
$508.1M
$763.8M
Q3 25
$511.5M
$742.8M
Q2 25
$513.1M
$595.8M
Q1 25
$519.4M
$564.6M
Q4 24
$534.0M
$493.4M
Q3 24
$374.1M
$488.0M
Q2 24
$374.4M
$591.6M
Debt / Equity
PRCT
PRCT
TPB
TPB
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
TPB
TPB
Operating Cash FlowLast quarter
$24.9M
Free Cash FlowOCF − Capex
$21.5M
FCF MarginFCF / Revenue
17.8%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
3.03×
TTM Free Cash FlowTrailing 4 quarters
$43.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
TPB
TPB
Q1 26
Q4 25
$-10.3M
$24.9M
Q3 25
$-6.6M
$3.3M
Q2 25
$-15.0M
$11.8M
Q1 25
$-17.0M
$17.4M
Q4 24
$-32.4M
$17.7M
Q3 24
$-18.8M
$13.2M
Q2 24
$-15.7M
$13.4M
Free Cash Flow
PRCT
PRCT
TPB
TPB
Q1 26
Q4 25
$-12.2M
$21.5M
Q3 25
$-9.5M
$-721.0K
Q2 25
$-17.8M
$7.8M
Q1 25
$-18.8M
$15.2M
Q4 24
$-33.6M
$16.6M
Q3 24
$-19.0M
$12.6M
Q2 24
$-16.8M
$10.9M
FCF Margin
PRCT
PRCT
TPB
TPB
Q1 26
Q4 25
-15.9%
17.8%
Q3 25
-11.4%
-0.6%
Q2 25
-22.5%
6.7%
Q1 25
-27.2%
14.3%
Q4 24
-49.2%
17.8%
Q3 24
-32.6%
13.9%
Q2 24
-31.4%
11.7%
Capex Intensity
PRCT
PRCT
TPB
TPB
Q1 26
Q4 25
2.4%
2.8%
Q3 25
3.4%
3.4%
Q2 25
3.5%
3.4%
Q1 25
2.7%
2.1%
Q4 24
1.7%
1.2%
Q3 24
0.4%
0.7%
Q2 24
2.0%
2.7%
Cash Conversion
PRCT
PRCT
TPB
TPB
Q1 26
Q4 25
3.03×
Q3 25
0.16×
Q2 25
0.82×
Q1 25
1.21×
Q4 24
7.34×
Q3 24
1.07×
Q2 24
1.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

TPB
TPB

US$111.5M92%
Non Us$9.6M8%

Related Comparisons